Advertisement

Topics

Gene Therapy Reimbursement: Is Blindness A Bad First Test?

22:17 EDT 28 Jun 2017 | SCRIP

The first gene therapy approval could be coming soon – followed shortly by the first ever gene therapy coverage decision...

      

Related Stories

 

Original Article: Gene Therapy Reimbursement: Is Blindness A Bad First Test?

NEXT ARTICLE

More From BioPortfolio on "Gene Therapy Reimbursement: Is Blindness A Bad First Test?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...